⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3625653 | 0.92 | — | — | |
| Water SCHEMBL27812755 | 0.89 | ALDH1A1 (0.44) | — | |
| SCHEMBL11921051 | 0.78 | — | — | |
| SCHEMBL14275986 | 0.78 | — | — | |
| SCHEMBL13654799 | 0.78 | — | — | |
| SCHEMBL12269087 | 0.78 | — | — | |
| SCHEMBL12022802 | 0.78 | — | — | |
| SCHEMBL25062001 | 0.74 | ALDH1A1 (0.48) | — | |
| SCHEMBL13083359 | 0.74 | HTT (0.33) | — | |
| SCHEMBL17796960 | 0.74 | POLB (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1889642-B1 | Cosmetic compositions combining a C-glycoside derivative and a N-acylaminoamide derivative | OREAL (FR) | 2019-05-08 | — | — | EP | disclosed |
| US-20180064824-A1 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | MERCK SHARP & DOHME CORP. (US) | 2018-03-08 | — | — | US | disclosed |
| US-9745355-B2 | Binding-site modified lectins and uses thereof | SMARTCELLS, INC. (US) | 2017-08-29 | — | — | US | disclosed |
| US-9579391-B2 | Conjugate based systems for controlled drug delivery | SMARTCELLS, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-20170022262-A1 | CRYSTALLINE INSULIN-CONJUGATES | SMARTCELLS, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| US-9463249-B2 | Crystalline insulin-conjugates | SMARTCELLS, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-20160193351-A1 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | SMARTCELLS, INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-9265838-B2 | Conjugate based systems for controlled drug delivery | SMART CELLS, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150265717-A1 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | SMARTCELLS, INC. (US) | 2015-09-24 | — | — | US | disclosed |
| US-9114176-B2 | Exogenously triggered controlled release materials and uses thereof | SMARTCELLS, INC. (US) | 2015-08-25 | — | — | US | disclosed |
| US-7419970-B2 | Aging resistance; controlling skin elasticity; example: ethyl {2-[acetyl(3-trifluoromethyl-phenyl)amino]-3-methylbutyrylamino}acetate; of slowing down the degradation activity of the elastic fibres of the intercellular spaces, may make it possible to reduce this phenomenon of accelerated ageing of skin | L'OREAL (FR) | 2008-09-02 | — | — | US | disclosed |
| EP-1743900-B1 | Organic compounds, organometallic complexes, organic electroluminescent display devices using the complexes and method for preparation of the devices | SAMSUNG SDI CO LTD (KR) | 2008-08-13 | — | — | EP | disclosed |
| EP-1889642-A2 | Cosmetic compositions combining a C-glycoside derivative and a N-acylaminoamide derivative | L'OREAL (FR) | 2008-02-20 | — | — | EP | disclosed |
| US-20080014230-A1 | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | L'OREAL (FR) | 2008-01-17 | — | — | US | disclosed |
| US-20080014230-A1 | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | L'OREAL (FR) | 2008-01-17 | — | — | US | disclosed |
| EP-1269988-B1 | Cosmetic or dermatological composition comprising acylaminoamide derivatives | OREAL (FR) | 2007-12-05 | — | — | EP | disclosed |
| EP-1626976-B1 | OLEFIN POLYMERIZATION CATALYST SYSTEM | EXXONMOBIL CHEM PATENTS INC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-7282586-B1 | Dipyridine-based compound and the use thereof | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2007-10-16 | — | — | US | disclosed |
| EP-1275372-B1 | Cosmetic or dermatological composition comprising a N-acylaminoamide derivative and a metalloproteinase inhibitor | OREAL (FR) | 2007-06-13 | — | — | EP | disclosed |
| EP-1399113-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING N-ACYLAMINOAMIDE DERIVATIVES | OREAL (FR) | 2007-03-21 | — | — | EP | disclosed |